Search for tag: "drug"

23 Media

59:29 210930 - M1 - 8am - PHAR - Intro to Pharmacology… 210930 - M1 - 8am - PHAR - Intro to Pharmacology - Negus	210930 - M1 - 8am - PHAR - Intro to Pharmacology - Negus som drug drugs receptor molecule neurotransmitter organism receptors effects effect things cells molecules chemical thing pharmacokinetics body morphine neurons ways cell From somvideo School of Medicine on September 30th, 2021 123 plays 0
01:06:06 TRIPN 6/2021 Maryam Lustberg, MD, MPH TRIPN 6/2021 Maryam Lustberg, MD, MPH	TRIPN 6/2021 Maryam Lustberg, MD, MPH Translational Research Initiative for Pain and Neuropathy (TRIPN) Research Seminar June 24, 2021 Emerging Strategies in Management of Cancer Treatment-Related Toxicities Presented by: Maryam… cancer neuropathy cipn translational research pain toxicity chemotherapy symptom risk prevention patient treatment drug paclitaxel drugs pathways From Teri Dulong-Rae on June 25th, 2021 3 plays 0
01:22:04 Palliative ECHO: Safety in Opioid Use in Serious… Palliative ECHO: Safety in Opioid Use in Serious Illness (Apr. 2019)	Palliative ECHO: Safety in Opioid Use in Serious Illness (Apr. 2019) Palliative ECHO: Safety in Opioid Use in Serious Illness \| April 25, 2019 Presented byEgidio Del Fabbro, MD Palliative Care Endowed Chair, VCU Massey Cancer Center ObjectivesReview risk assessment… opioids substance use disorders risk assessment pain chemical coping opioid addiction opioid tolerance chronic pain urine drug screen patients patient care lot things hospice disorder dose substance medications factors medication cancer history team feedback risk questions From Teri Dulong-Rae on June 1st, 2021 1 plays 0
51:36 Palliative ECHO: Methadone use in supportive Care… Palliative ECHO: Methadone use in supportive Care (Aug. 2019)	Palliative ECHO: Methadone use in supportive Care (Aug. 2019) Palliative ECHO: Methadone use in supportive Care \| Aug. 8, 2019 Presented byEgidio Del Fabbro, MDPalliative Care Endowed Chair, VCU Massey Cancer Center ObjectivesDescribe how methadone differs… methadone opioids substance use disorder palliative palliative care palliative medicine patients pain dose recommendations morphine questions patient drugs milligrams study therapy drug hospice ess neuropathy risk question substance From Teri Dulong-Rae on June 1st, 2021 0 plays 0
53:51 Palliative ECHO: Substance Abuse in Palliative… Palliative ECHO: Substance Abuse in Palliative Care (Jun. 2020)	Palliative ECHO: Substance Abuse in Palliative Care (Jun. 2020) Palliative ECHO: Substance Abuse \| June 22, 2020 Presented byAlina Fomovska, MD University of Virginia Palliative Medicine Fellow Objectives:Discuss options for pain management in palliative… substance use disorder substance abuse palliative palliative medicine palliative care pain management pain patients patient care substance medications risk buprenorphine opiate clinic drug misuse medication opiates approach hospital disorder lot providers From Teri Dulong-Rae on May 25th, 2021 0 plays 0
01:22:26 Bench to Community Seminar - Series 1, Session 5:… Bench to Community Seminar - Series 1, Session 5: FDA Regulatory Pathways and Requirements	Bench to Community Seminar - Series 1, Session 5: FDA Regulatory Pathways and Requirements This session will provide an overview of regulatory approval and commercialization issues impacting companies developing medical devices, drugs, and biologic products. Attendees will be able to… institute for engineering and medicine office of research and innovation ovpri regulatory requirements intellectual property product development product planning innovation iteration medical device development medical equipment medical device commercialization translational research community engaged research project funding biologics funding marketing strategy device fda class lot drug devices things market application trials safety sort idea questions companies question process combination drugs quality From Laura Osborne on March 19th, 2021 5 plays 0 Data Classification CATEGORY I DATA
54:51 210120-M1-1030am-MARR-Targeted Antineoplastics… 210120-M1-1030am-MARR-Targeted Antineoplastics Medications: Hematologic Neoplasms-Gatesman	210120-M1-1030am-MARR-Targeted Antineoplastics Medications: Hematologic Neoplasms-Gatesman somtech drug inhibitors cell agents patients toxicities cells risk nib toxicity class patient agent drugs disease lot cancer differentiation infection infusion From somvideo School of Medicine on January 20th, 2021 68 plays 0
04:45 CEA - Part 3 CEA - Part 3	CEA - Part 3 pharmacoeconomics drug effectiveness cost care standard treatment hepatitis heart drugs icer attack hospitalization costs strategy answer scenario kidney hep options decision From Julie Patterson on December 14th, 2020 119 plays 0
16:26 CEA - Part 2 CEA - Part 2	CEA - Part 2 pharmacoeconomics cost effectiveness analysis hepatitis evidence perspective study horizon population treatment quality outcome costs comparator outcomes drug kidney patients donor dialysis From Julie Patterson on December 14th, 2020 147 plays 0
55:41 201210 - M2 - 10am - MBB - General Principles,… 201210 - M2 - 10am - MBB - General Principles, Opioids, and Cannabinoids - Selley	201210 - M2 - 10am - MBB - General Principles, Opioids, and Cannabinoids - Selley som drug drugs abuse morphine opioids dependence cannabis thc effects marijuana heroin cannabinoids efficacy receptors tolerance opium withdrawal opioid symptoms effect From somvideo School of Medicine on December 10th, 2020 112 plays 0
52:59 201210 - M2 - 9am - MBB - Pain Management and… 201210 - M2 - 9am - MBB - Pain Management and Prescription Opioid Abuse - Moeller	201210 - M2 - 9am - MBB - Pain Management and Prescription Opioid Abuse - Moeller som pain opioids patients disorder patient treatment overdose risk prescription withdrawal epidemic medications history deaths substance drug benzodiazepines things issue symptoms From somvideo School of Medicine on December 10th, 2020 107 plays 0
56:38 201210 - M2 - 8am - MBB - Introduction to… 201210 - M2 - 8am - MBB - Introduction to Substance Use Disorder Symptomatology, Risk Factors, and Biological Models - Bjork	201210 - M2 - 8am - MBB - Introduction to Substance Use Disorder Symptomatology, Risk Factors, and Biological Models - Bjork som dopamine alcohol drug brain lot addiction environment drugs guys substance bit things reward circuitry abuse thing disorder question cocaine prescription From somvideo School of Medicine on December 10th, 2020 111 plays 0
51:26 201202 - M2 - 8am - MBB - Psychiatric… 201202 - M2 - 8am - MBB - Psychiatric Epidemiology and Behavioral Genetics - Kendler	201202 - M2 - 8am - MBB - Psychiatric Epidemiology and Behavioral Genetics - Kendler som disorders rates alcohol depression suicide study genetics studies epidemiology population families americans drug lots areas gun abuse anxiety disorder things From somvideo School of Medicine on December 2nd, 2020 104 plays 0
53:28 201112 - M1 - 11am - I&I - Drugs and Immune… 201112 - M1 - 11am - I&I - Drugs and Immune System - Kakadiya	201112 - M1 - 11am - I&I - Drugs and Immune System - Kakadiya som cell patients cells response antibodies inhibitors activation drug hypersensitivity reaction question diseases corticosteroids child antigen disease bit risk biologics antibody From somvideo School of Medicine on November 12th, 2020 131 plays 0
01:34:48 201112-M2-8am-MBB-Epilepsy Syndromes and… 201112-M2-8am-MBB-Epilepsy Syndromes and Treatment-Waterhouse	201112-M2-8am-MBB-Epilepsy Syndromes and Treatment-Waterhouse somtech seizure seizures onset person epilepsy eeg brain risk things side bit kind tonic drugs channel gaba neurons motor patient drug From somvideo School of Medicine on November 12th, 2020 147 plays 0
01:26:47 201016-M2-1030am-RENL-Review-Vinnikova 201016-M2-1030am-RENL-Review-Vinnikova	201016-M2-1030am-RENL-Review-Vinnikova somtech kidney calcium disease patients hypertension patient cells urine things blood dialysis drug stones pressure drugs cell phosphate levels side treatment From somvideo School of Medicine on October 16th, 2020 68 plays 0